Credits Available: | These activities have been approved for AMA PRA Category 1 Credit(s)™, and certified for ANCC Contact Hours (including pharmacotherapeutic contact hours) and California Board of Nursing Contact Hours (Time to complete: Self Study 2.0 hrs; Live Group Discussion 1: 0.5 hrs; Live Group Discussion 2: 0.5 hrs) |
The goal of this experience is to educate clinicians about caring for patients with tenosynovial giant cell tumor (TGCT). Members of the care team are challenged by the rarity of the disease and determining appropriate treatment approaches. To successfully overcome these challenges, clinicians who care for patients with TGCT must be able to identify patients with TGCT and refer to or partner with tertiary care centers for multidisciplinary management, discuss the benefits and risks of available treatment options for localized and diffuse TGCT, and create a collaborative, individualized TGCT treatment plan.
This self-assessment will assess your understanding of tenosynovial giant cell tumor (TGCT). It will assess your knowledge about identifying patients with TGCT, the benefits and risks of available treatment options, and individualized treatment plans.
This module focuses on important aspects of tenosynovial giant cell tumor (TGCT), including terminology, types, epidemiology, pathophysiology, diagnosis, and clinical presentation. It concludes with guidance on the importance of appropriate referral for this rare condition.
This module discusses the historical approach to tenosynovial giant cell tumor (TGCT) and the current approach to managing this rare condition. Approved, off-label, and investigational agents are discussed.
This module addresses medical therapy and surgery considerations in the management of tenosynovial giant cell tumor (TGCT). It also includes discussion about shared decision-making and the importance of a multidisciplinary, interprofessional approach.
This self-assessment will assess your understanding of tenosynovial giant cell tumor (TGCT). It will assess your knowledge about identifying patients with TGCT, the benefits and risks of available treatment options, and individualized treatment plans.
The first web conference will focus on identifying patients with TGCT, benefits and risk of medical therapies, and personalizing care for patients with TGCT.
The second web conference will focus on reviewing the patient case and group tasks and how the findings can apply to caring for current or future patients with TGCT.
This group task will focus on the management of a patient with localized TGCT.
This group task will focus on the management of a patient with diffuse TGCT.
Thank you for your interest. Currently, the curriculum is closed for enrollment but we encourage you to keep an eye out for future opportunities or alternative programs that might align with your educational goals.